Clinical trials by condition

Myelodysplastic syndrome (MDS) clinical trials near you

185 studies for myelodysplastic syndrome (MDS) are recruiting volunteers at 870 research sites in 50 states.

Also called myelodysplasia, myelodysplastic syndromes.

Part of Blood cancers

Studies recruiting
185
Research sites
870
States
50

What is myelodysplastic syndrome (MDS)?

Myelodysplastic syndrome is a condition in which the stem cells in the bone marrow do not mature into healthy blood cells. Bone marrow is the spongy tissue inside some bones, and its stem cells normally become red blood cells, white blood cells and platelets.

Without enough healthy blood cells, a person can get infections, anemia or easy bleeding. The condition often causes no early symptoms and is sometimes found during a routine blood test. When there are symptoms, they can include shortness of breath, weakness or tiredness, paler skin, easy bruising or bleeding, and fever or frequent infections.

Myelodysplastic syndromes are rare. People at higher risk are over 60, have had chemotherapy or radiation therapy, or have been exposed to certain chemicals. Treatment options include transfusions, drug therapy, chemotherapy, and blood or bone marrow stem cell transplants.

Written with AI from MedlinePlus, the National Library of Medicine's health information, and checked by an AI medical reviewer on November 13, 2026. Read more on MedlinePlus

Areas with the most myelodysplastic syndrome (MDS) studies

Metro areas where studies for myelodysplastic syndrome (MDS) are recruiting, each study counted once in an area.

  1. 1HoustonTexas52 studies
  2. 2Los AngelesCalifornia43 studies
  3. 3New YorkNew York42 studies
  4. 4SeattleWashington26 studies
  5. 5WashingtonDistrict of Columbia26 studies
  6. 6BostonMassachusetts25 studies
  7. 7TampaFlorida22 studies
  8. 8ColumbusOhio20 studies
  9. 9MiamiFlorida20 studies
  10. 10ChicagoIllinois19 studies

By state

Studies for myelodysplastic syndrome (MDS) recruiting in each state.

  • Texas55 studies · 52 sites
  • California49 studies · 82 sites
  • New York45 studies · 56 sites
  • Florida39 studies · 47 sites
  • Maryland29 studies · 22 sites
  • Washington26 studies · 17 sites
  • Massachusetts25 studies · 16 sites
  • Ohio25 studies · 27 sites
  • North Carolina22 studies · 32 sites
  • Pennsylvania22 studies · 27 sites
All 50 states

Whom the studies accept

The share of the myelodysplastic syndrome (MDS) studies open to each group. A study can accept several.

  • Adults 18 to 6498%
  • Adults 65 and over89%
  • Children and teens (under 18)30%
  • Healthy volunteers8%
  • Open to all sexes99%
  • Women only1%

Study phases

Earlier phases test safety in fewer people; later phases compare a treatment with the usual care in many.

  • Early phase 12%
  • Phase 129%
  • Phase 1/212%
  • Phase 232%
  • Phase 2/31%
  • Phase 33%
  • No phase (device, behavioral and other studies)6%
  • Not stated15%

Cite these figures

Free to use under CC BY 4.0. Please credit LocalTrial with a link to this page.

As text

Source: LocalTrial, Myelodysplastic syndrome (MDS) clinical trials near you, https://www.localtrial.com/clinical-trials/conditions/myelodysplastic-syndrome, updated November 13, 2026.

With the link, for a web page

Source: <a href="https://www.localtrial.com/clinical-trials/conditions/myelodysplastic-syndrome">LocalTrial, Myelodysplastic syndrome (MDS) clinical trials near you</a>, updated November 13, 2026.

About these figures

Counted from ClinicalTrials.gov, the U.S. registry of clinical studies, for studies recruiting in the United States that study myelodysplastic syndrome (MDS). A study is counted once however many sites it has.

Updated November 13, 2026.

These figures describe studies, not advice. Talk to your doctor before joining one.

Tell us a little about yourself and we'll suggest the myelodysplastic syndrome (MDS) studies near you that may fit. Free and private.

Find myelodysplastic syndrome (MDS) studies near me